Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2006, Article ID 32071, 6 pages
Research Communication

TLR2 Expression in Relation to IL-6 and IL-1β and their Natural Regulators Production by PMN and PBMC in Patients with Lyme Disease

Department of Immunology, Medical University of Bialystok, Wyszynskiego 15A, Bialystok 15274, Poland

Received 8 November 2005; Revised 24 November 2005; Accepted 24 November 2005

Copyright © 2006 Ewa Jablonska and Magdalena Marcinczyk. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S E Doyle, R M O'Connell, G A Miranda et al., “Toll-like receptors induce a phagocytic gene program through p38,” The Journal of Experimental Medicine, vol. 199, no. 1, pp. 81–90, 2004. View at Publisher · View at Google Scholar
  2. I Sabroe, R C Read, M KB Whyte, D H Dockrell, S N Vogel, and S K Dower, “Toll-like receptors in health and disease: complex questions remain,” The Journal of Immunology, vol. 171, no. 4, pp. 1630–1635, 2003. View at Google Scholar
  3. O Takeuchi and S Akira, “Genetic approaches to the study of Toll-like receptor function,” Microbes and Infection, vol. 4, no. 9, pp. 887–895, 2002. View at Publisher · View at Google Scholar
  4. I Sabroe, L R Prince, E C Jones et al., “Selective roles for Toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span,” The Journal of Immunology, vol. 170, no. 10, pp. 5268–5275, 2003. View at Google Scholar
  5. T H Flo, Ø Halaas, S Torp et al., “Differential expression of Toll-like receptor 2 in human cells,” Journal of Leukocyte Biology, vol. 69, no. 3, pp. 474–481, 2001. View at Google Scholar
  6. D Zhang, G Zhang, M S Hayden et al., “A Toll-like receptor that prevents infection by uropathogenic bacteria,” Science, vol. 303, no. 5663, pp. 1522–1526, 2004. View at Publisher · View at Google Scholar
  7. F Hayashi, T K Means, and A D Luster, “Toll-like receptors stimulate human neutrophil function,” Blood, vol. 102, no. 7, pp. 2660–2669, 2003. View at Publisher · View at Google Scholar
  8. Y Bulut, E Faure, L Thomas, O Equils, and M Arditi, “Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling,” The Journal of Immunology, vol. 167, no. 2, pp. 987–994, 2001. View at Google Scholar
  9. E Lien, T J Sellati, A Yoshimura et al., “Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products,” The Journal of Biological Chemistry, vol. 274, no. 47, pp. 33419–33425, 1999. View at Publisher · View at Google Scholar
  10. D Lusitani, S E Malawista, and R R Montgomery, “Borrelia burgdorferi are susceptible to killing by a variety of human polymorphonuclear leukocyte components,” The Journal of Infectious Diseases, vol. 185, no. 6, pp. 797–804, 2002. View at Publisher · View at Google Scholar
  11. M A Cassatella, “The production of cytokines by polymorphonuclear neutrophils,” Immunology Today, vol. 16, no. 1, pp. 21–26, 1995. View at Publisher · View at Google Scholar
  12. E Jablonska, M Marcinczyk, A Izycka, and T Hermanowska-Szpakowicz, “Effect of interleukin 15 on the PMN activity in Lyme borreliosis,” Polski Merkuriusz Lekarski, vol. 15, no. 87, pp. 249–252, 2003 (Polish). View at Google Scholar
  13. P P McDonald, M P Russo, S Ferrini, and M A Cassatella, “Interleukin-15 (IL-15) induces NF-κB activation and IL-8 production in human neutrophils,” Blood, vol. 92, no. 12, pp. 4828–4835, 1998. View at Google Scholar
  14. P Roux-Lombard, “The interleukin-1 family,” European Cytokine Network, vol. 9, no. 4, pp. 565–576, 1998. View at Google Scholar
  15. E Jablonska and M Marcinczyk, “Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils,” Mediators of Inflammation, vol. 12, no. 3, pp. 179–183, 2003. View at Publisher · View at Google Scholar
  16. E Jabłońska, M Marcińczyk, Ł Talarek, S Pancewicz, T Hermanowska-Szpakowicz, and J Jabłoński, “IL-15 in the culture supernatants of PMN and PBMC and the serum of patients with Lyme disease,” Roczniki Akademii Medycznej w Białymstoku, vol. 48, pp. 78–81, 2003. View at Google Scholar
  17. D Girard, M E Paquet, R Paquin, and A D Beaulieu, “Differential effects of interleukin-15 (IL-15) and IL-2 on human neutrophils: modulation of phagocytosis, cytoskeleton rearrangement, gene expression, and apoptosis by IL-15,” Blood, vol. 88, no. 8, pp. 3176–3184, 1996. View at Google Scholar
  18. R M Wooten, Y Ma, R A Yoder et al., “Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi,” The Journal of Immunology, vol. 168, no. 1, pp. 348–355, 2002. View at Google Scholar
  19. G H Giambartolomei, V A Dennis, B L Lasater, and M T Philipp, “Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14,” Infection and Immunity, vol. 67, no. 1, pp. 140–147, 1999. View at Google Scholar
  20. T Häupl, S Landgraf, P Netusil et al., “Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines,” FEMS Immunology and Medical Microbiology, vol. 19, no. 1, pp. 15–23, 1997. View at Google Scholar
  21. G M Barton and R Medzhitov, “Control of adaptive immune responses by Toll-like receptors,” Current Opinion in Immunology, vol. 14, no. 3, pp. 380–383, 2002. View at Publisher · View at Google Scholar
  22. R Schindler, J Mancilla, S Endres, R Ghorbani, S C Clark, and C A Dinarello, “Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF,” Blood, vol. 75, no. 1, pp. 40–47, 1990. View at Google Scholar
  23. E A Brown, H A Dare, C B Marsh, and M D Wewers, “The combination of endotoxin and dexamethasone induces type II interleukin 1 receptor (IL-1r II) in monocytes: a comparison to interleukin 1 β (IL-1 β) and interleukin 1 receptor antagonist (IL-1ra),” Cytokine, vol. 8, no. 11, pp. 820–836, 1996. View at Publisher · View at Google Scholar
  24. L E DeForge, D E Tracey, J S Kenney, and D G Remick, “Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood,” The American Journal of Pathology, vol. 140, no. 5, pp. 1045–1054, 1992. View at Google Scholar
  25. A J Puren, P Razeghi, G Fantuzzi, and C A Dinarello, “Interleukin-18 enhances lipopolysaccharide-induced interferon-γ production in human whole blood cultures,” The Journal of Infectious Diseases, vol. 178, no. 6, pp. 1830–1834, 1998. View at Publisher · View at Google Scholar
  26. L C Miller, S Isa, E Vannier, K Georgilis, A C Steere, and C A Dinarello, “Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist,” The Journal of Clinical Investigation, vol. 90, no. 3, pp. 906–912, 1992. View at Google Scholar
  27. T Musikacharoen, T Matsuguchi, T Kikuchi, and Y Yoshikai, “NF-κ B and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression,” The Journal of Immunology, vol. 166, no. 7, pp. 4516–4524, 2001. View at Google Scholar